Publication | Closed Access

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

OncologyCervical CancerMetronomic TherapyPathologyRecurrent Cervical CancerCancer TreatmentMedicineRadiation OncologyGynecology Oncology